Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome
Recruiting
Phase 2
Interventional Study
Refractive Error Correction
Visual Acuity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 5 – 12
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 24 (estimated)
- Sponsor
- Ohio State University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study seeks to determine whether glasses prescriptions determined from computer analysis of detailed images of the eyes provide better vision outcomes for children with Down syndrome than prescriptions determined using routine clinical methods.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Down syndrome
* Age 5 to 12 years
* Ability to sit for study measures
* Able to be dilated
Exclusion Criteria:
* Nystagmus
* History of Ocular or Refractive Surgery
* Corneal or lenticular opacities
* Ocular disease
* Anisometropic or strabismic amblyopia
* Contact allergy t…
Contacts